Verbesserte Detektion von Leberläsionen durch Ultraschall-Kontrastmittel der zweiten Generation im Vergleich zur konventionellen Sonografie

Autor: François Tranquart, A. Ignee, L. Bolondi, T. Albrecht, T. Livraghi, Christoph F. Dietrich
Rok vydání: 2009
Předmět:
Zdroj: Endoskopie heute. 22:105-109
ISSN: 1439-2577
0933-811X
DOI: 10.1055/s-0029-1224498
Popis: AIM: Aim of this first prospective international multicentre phase III b study was the comparison of unenhanced (US) and contrast enhanced ultrasound (CEUS) with contrast enhanced spiral computed tomography (CT) and/or contrast enhanced magnetic resonance imaging (MRI) in the detec-tion of focal liver lesions. METHODS: 77 patients (73 per protocol) with liver lesions (primary or secondary liver lesions) were enrolled. After conventional ultrasound examination up to 3 injections of 2.4 or 4.8 mL SonoVue® were injected. Scans were repeated using contrast-specific imaging. Detection of lesions before and after contrast medium injection was com-pared using MRI and / or CT as the standard of reference. RESULTS: US detected 106 / 160 reference con-firmed liver lesions (sensitivity and positive predictive value (PPV) of 66 % and 77 %, respectively). CEUS detected 127 / 160 reference confirmed liver lesions (sensitivity and PPV of 79 % and 83 %, re-spectively). Five lesions were only detected using conventional unenhanced B-mode ultrasound, 26 lesions were only detected with CEUS. 27 / 154 lesions in 73 patients (17.5 %) detected by CEUS could not be confirmed by the reference method and thus were considered false positive. No adverse events were reported. DISCUSSION: CEUS with SonoVue® improves the ability of ultrasound to detect liver lesions. The high rate of lesions detected with CEUS and not by the reference methods (false positive) is actually a general bias in detection studies, in which no absolute non-invasive gold standard is available. Therefore, the true PPV of CEUS may be higher than that reported in this study.
Databáze: OpenAIRE